Dexamethasone Liquid Clinical Trials

• Thal/Dex (Thalidomide and Dexamethasone) vs. Dd-T (Doxil, Dexamethasone and Thalidomide) in Multiple Myeloma Patients
  ClinicalTrials.gov Identifier: NCT00097981 - Active, not recruiting
  Multiple Myeloma
  
• Gemcitabine, Dexamethasone and Cisplatin Versus Dexamethasone, Cytarabine, Cisplatin in Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00089817 - Recruiting
  Lymphoma
  
• Interscalene Nerve Blocks With Ropivacaine Alone, With Dexamethasone,Plus Systemic Dexamethasone
  ClinicalTrials.gov Identifier: NCT00519584 - Recruiting
  Pain
  
• A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00424047 - Active, not recruiting
  Multiple Myeloma
  
• Vincristine, DOXIL® (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00344422 - Active, not recruiting
  M-Protein; Multiple Myeloma; Myeloma; Myeloma Proteins
  
• IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00200681 - Recruiting
  Multiple Myeloma
  
• Phase 1/2 Study of VELCADE®, Dexamethasone, and Revlimid® Versus VELCADE, Dexamethasone, Cyclophosphamide, and Revlimid in Patients With Previously Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00507442 - Recruiting
  Multiple Myeloma
  
• Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
  ClinicalTrials.gov Identifier: NCT00522392 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00176293 - Active, not recruiting
  Prostate Cancer
  
• CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects with Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00056160 - Active, not recruiting
  Multiple Myeloma
  
• Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00151203 - Active, not recruiting
  Multiple Myeloma
  
• An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children with HIV Infection: Canada
  ClinicalTrials.gov Identifier: NCT00162188 - Recruiting
  HIV Infection
  
• Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00116961 - Active, not recruiting
  Multiple Myeloma
  
• A Pilot Study of Combination Therapy with VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00135187 - Active, not recruiting
  Multiple Myeloma
  
• Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00458705 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• A Multicenter, Open-Label, Single-Arm, Expanded Access Program For Lenalidomide Plus Dexamethasone In Previously Treated Subjects With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00179647 - Recruiting
  Multiple Myeloma
  
• A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and Nausea.
  ClinicalTrials.gov Identifier: NCT00272285 - Active, not recruiting
  Vomiting; Nausea
  
• Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00441168 - Recruiting
  Multiple Myeloma
  
• The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis
  ClinicalTrials.gov Identifier: NCT00119002 - Recruiting
  Bronchiolitis, Viral
  
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
  refractory plasma cell neoplasm
  
• Dexamethasone Plus Interferon alfa in Treating Patients With Primary Systemic Amyloidosis
  ClinicalTrials.gov Identifier: NCT00002849 - Active, not recruiting
  primary systemic amyloidosis
  
• Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00084708 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Study of Topiramate Administered as Liquid or Sprinkles in Infants (Aged 1-23 Months) With Refractory POS
  ClinicalTrials.gov Identifier: NCT00233012 - Active, not recruiting
  Seizures
  
• Study of Three Capsaicin Dermal Liquid Formulations on Epidermal Nerve Fiber Immunostaining and Sensory Function
  ClinicalTrials.gov Identifier: NCT00528216 - Active, not recruiting
  Pain
  
• Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00074191 - Active, not recruiting
  intraocular lymphoma; primary central nervous system lymphoma
  
• Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of MEDI-493, Synagis
  ClinicalTrials.gov Identifier: NCT00233064 - Active, not recruiting
  Chronic Lung Disease
  
• Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00074178 - Active, not recruiting
  primary central nervous system lymphoma; intraocular lymphoma
  
• Dexamethasone Study
  ClinicalTrials.gov Identifier: NCT00152867 - Recruiting
  Cancer; Quality of Life; Emesis
  
• Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis
  ClinicalTrials.gov Identifier: NCT00089167 - Active, not recruiting
  primary systemic amyloidosis
  
• A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals’ HRV Liquid Vaccine in Healthy Infants.
  ClinicalTrials.gov Identifier: NCT00432380 - Active, not recruiting
  Rotavirus Gastroenteritis
  
• Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
  recurrent prostate cancer; Anemia; Fatigue
  
• Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00098475 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Liquid Meal Replacements in Conjunction With Lifestyle Intervention in Overweight Adolescents
  ClinicalTrials.gov Identifier: NCT00207519 - Active, not recruiting
  Overweight; Obesity
  
• Dexamethasone With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00064038 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• A Study in Infants to Test Two Preparations (Freeze-Dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).
  ClinicalTrials.gov Identifier: NCT00382772 - Active, not recruiting
  Gastroenteritis
  
• Ondansetron With or Without Dexamethasone to Prevent Vomiting in Patients Receiving Radiation Therapy to the Upper Abdomen
  ClinicalTrials.gov Identifier: NCT00016380 - Active, not recruiting
  Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; nausea and vomiting; Quality of Life
  
• Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00030069 - Recruiting
  Myelodysplastic Syndromes
  
• Aprepitant, Ondansetron, and Dexamethasone in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00248547 - Active, not recruiting
  Cancer
  
• Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00010231 - Active, not recruiting
  stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00017602 - Active, not recruiting
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00124579 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
  ClinicalTrials.gov Identifier: NCT00577993 - Active, not recruiting
  Lymphoma
  
• Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00250926 - Active, not recruiting
  Waldenstrom's Macroglobulinemia
  
• Efficacy and Safety Study of Oral Glycopyrrolate Liquid to Manage Problem Drooling Associated With Cerebral Palsy or Other Neurologic Conditions in Children
  ClinicalTrials.gov Identifier: NCT00425087 - Active, not recruiting
  Sialorrhea; Cerebral Palsy; Neurological Condition; Mental Retardation
  
• Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00017069 - Active, not recruiting
  refractory plasma cell neoplasm; stage II multiple myeloma; stage III multiple myeloma
  
• Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00021359 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00175877 - Active, not recruiting
  Rheumatoid Arthritis
  
• A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults
  ClinicalTrials.gov Identifier: NCT00437229 - Active, not recruiting
  Healthy Adult Volunteer
  
• A Multicentre, Single-Arm, Open-Label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00420849 - Active, not recruiting
  Multiple Myeloma
  
• Dexamethasone or Dexamethasone in Combination with Thalidomide as Salvage Therapy
  ClinicalTrials.gov Identifier: NCT00083902 - Completed
  Multiple Myeloma
  
• Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00227682 - Active, not recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Dexamethasone for Palliation - Brain Metastases
  ClinicalTrials.gov Identifier: NCT00188864 - Recruiting
  Neoplasm Metastasis
  
• A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00478777 - Active, not recruiting
  Relapsed or Refractory Multiple Myeloma
  
• Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00375791 - Active, not recruiting
  Multiple Myeloma
  
• Dexamethasone for Symptom Burden in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00489307 - Recruiting
  Solid Tumors
  
• Bortezomib-Dexamethasone-Doxorubicin-Study
  ClinicalTrials.gov Identifier: NCT00401804 - Recruiting
  Multiple Myeloma; Renal Insuficiency
  
• Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate
  ClinicalTrials.gov Identifier: NCT00084864 - Recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
  
• Total Therapy II
  ClinicalTrials.gov Identifier: NCT00083551 - Active, not recruiting
  Multiple Myeloma
  
• Efficacy of Intravenous Dexamethasone for Acute Disc Herniation-Induced Sciatica
  ClinicalTrials.gov Identifier: NCT00516009 - Recruiting
  RADICULAR PAIN
  
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003397 - Active, not recruiting
  Lymphoma
  
• Evaluation of Liquid vs. Tablet Buprenorphine - 6
  ClinicalTrials.gov Identifier: NCT00000341 - Active, not recruiting
  Opioid-Related Disorders
  
• Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns with Lupus
  ClinicalTrials.gov Identifier: NCT00007358 - Recruiting
  Congenital heart block; Neonatal lupus; Atrioventricular nodal dysfunction; Myocardial injury
  
• Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00261612 - Active, not recruiting
  Lymphoma, Mantle-Cell
  
• Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children
  ClinicalTrials.gov Identifier: NCT00312091 - Recruiting
  HIV Infections
  
• Drugs to Reduce the Side Effects of Chemotherapy
  ClinicalTrials.gov Identifier: NCT00003213 - Active, not recruiting
  solid tumor; Nausea; Vomiting
  
• High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease
  ClinicalTrials.gov Identifier: NCT00247143 - Recruiting
  HIV; AIDS
  
• Randomized Study of Albendazole in Patients with Epilepsy Due to Neurocysticercosis
  ClinicalTrials.gov Identifier: NCT00004403 - Active, not recruiting
  Epilepsy; Cysticercosis
  
• Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002471 - Active, not recruiting
  Lymphoma; Leukemia
  
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003402 - Active, not recruiting
  Lymphocytic Lymphoma
  
• Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00258245 - Active, not recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• A Study of the Safety of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients with Active Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00160641 - Active, not recruiting
  Rheumatoid Arthritis
  
• Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants with Brain Tumors
  ClinicalTrials.gov Identifier: NCT00042367 - Active, not recruiting
  Brain Tumors
  
• Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of PVR
  ClinicalTrials.gov Identifier: NCT00370760 - Recruiting
  Proliferative Vitreoretinopathy
  
• Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
  ClinicalTrials.gov Identifier: NCT00564889 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients with Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00071201 - Active, not recruiting
  Chronic Hepatitis B
  
• Velcade and Dexamethasone in Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00391157 - Active, not recruiting
  Multiple Myeloma
  
• Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)
  ClinicalTrials.gov Identifier: NCT00492284 - Recruiting
  Choroidal Neovascularization; Macular Degeneration
  
• DTPACE followed by Tandem Transplant with MEL 200 versus MEL/DTPACE Hybrid and DTPACE Consolidation
  ClinicalTrials.gov Identifier: NCT00083915 - Active, not recruiting
  Multiple Myeloma
  
• Phase 2 Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive ALL
  ClinicalTrials.gov Identifier: NCT00130195 - Active, not recruiting
  Acute Lymphoblastic Leukemia
  
• Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
  ClinicalTrials.gov Identifier: NCT00520767 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma
  ClinicalTrials.gov Identifier: NCT00561301 - Recruiting
  Lymphoma
  
• Rituximab and Dexamethasone in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00244855 - Recruiting
  Lymphoma
  
• Single Dose Versus Multiple Doses of Dexamethasone in Children With Acute Bronchiolitis
  ClinicalTrials.gov Identifier: NCT00213226 - Recruiting
  Bronchiolitis
  
• Bio-Availability of a New Liquid Tumeric Extract
  ClinicalTrials.gov Identifier: NCT00542711 - Not yet recruiting
  Healthy
  
• The Effect of Gabapentin, Ketamine and Dexamethasone on Pain and Opioid Requirements After Hip Surgery
  ClinicalTrials.gov Identifier: NCT00236223 - Recruiting
  Pain, Postoperative
  
• To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis
  ClinicalTrials.gov Identifier: NCT00372294 - Recruiting
  Toxoplasmic Chorioretinitis
  
• Effect of Paracetamol, Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients Having a Tonsillectomy
  ClinicalTrials.gov Identifier: NCT00378547 - Recruiting
  Pain, Postoperative
  
• High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP
  ClinicalTrials.gov Identifier: NCT00451594 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Six Months, Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation in Adolescents (>12 Years) and Adults With Moderate to Severe Persistent Allergic Asthma
  ClinicalTrials.gov Identifier: NCT00500539 - Recruiting
  Asthma
  
• Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma
  ClinicalTrials.gov Identifier: NCT00166439 - Recruiting
  Lymphoma
  
• Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma
  ClinicalTrials.gov Identifier: NCT00275106 - Recruiting
  Lymphoma
  
• Dexamethasone for Cardiac Surgery Trial
  ClinicalTrials.gov Identifier: NCT00293592 - Recruiting
  Systemic Inflammatory Response Syndrome; Cardiac Diseases; Postoperative Complications
  
• Safety and Efficacy of Intratympanic Application of Dexamethasone Via Catheter in Patients With Sudden Hearing Loss
  ClinicalTrials.gov Identifier: NCT00335920 - Recruiting
  Sudden Deafness
  
• Dexamethasone for Paediatric Adeno-Tonsillectomy - A Dose-Finding Study
  ClinicalTrials.gov Identifier: NCT00403806 - Recruiting
  Postoperative Nausea and Vomiting; Postoperative Pain
  
• Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00112879 - Recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00075725 - Recruiting
  untreated childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia; ...
  
• Efficacy and Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combination With Ondansetron and Dexamethasone in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00314743 - Recruiting
  Nausea; Vomiting
  
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002665 - Active, not recruiting
  Thrombocytopenia; Leukemia, Lymphocytic; Neutropenia
  
• PS-341 in Treating Patients With Refractory or Progressive Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049478 - Active, not recruiting
  refractory plasma cell neoplasm